Paroxysmal atrial fibrillation

Digitoxin is used for chronic cardiac insufficiency, tachyarrhythmia form of atrial fibrillation, paroxysmal ciliary arrhythmia, and paroxysmal supraventricular tachycaria. Synonyms of this drag are cardigin, cordalin, crystodigin, purodigin, and others. [Pg.240]

Cardiovascular Cardiac dysrhythmias (atrial fibrillation, paroxysmal atrial fibrillation, sinus pauses, and bradycardia) have been attributed to ropinirole in four... [Pg.242]

The uses of the antiarrhythmic drug are given in the Summaiy Drug Table Antiarrhythmic Drug3. In general these drugp are used to prevent and treat cardiac arrhythmias, such as premature ventricular contractions (PVCs), ventricular tachycardia (VT), premature atrial contractions (PACs), paroxysmal atrial tachycardia (PAT), atrial fibrillation, and atrial flutter. Some of the antiarrhythmic dru are used for other... [Pg.370]

Fontana L Paroxysmal atrial fibrillation after insect sting. J Allergy Clin Immunol 1996 98 759. 24... [Pg.107]

Compare and contrast the risk factors for and the features, mechanisms, etiologies, symptoms, and goals of therapy of (1) sinus bradycardia (2) atrioventricular (AV) nodal blockade (3) atrial fibrillation (AF) (4) paroxysmal supraventricular tachycardia (PSVT) ... [Pg.107]

Atrial fibrillation is classified as paroxysmal, persistent, or permanent (Fig. 6-4).23 Patients with paroxysmal AF have episodes that start suddenly and spontaneously, last minutes... [Pg.116]

FIGURE 6-6. Decision algorithm for long-term ventricular rate control with oral drug therapy for patients with paroxysmal or permanent atrial fibrillation, bpm, beats per minute CCB, calcium channel blocker (diltiazem or verapamil) HF, heart failure LV, left ventricular function LVEF, left ventricular ejection fraction. (Algorithm adapted with permission from Tisdale JE, Moser LR. Tachyarrhythmias. In Mueller BA, Bertch KE, Dunsworth TS, et al. (eds.) Pharmacotherapy Self-Assessment Program, 4th ed. Kansas City American College of Clinical Pharmacy 2001 ... [Pg.120]

Common supraventricular tachycardias requiring drug treatment are atrial fibrillation (AF) or atrial flutter, paroxysmal supraventricular tachycardia (PSVT), and automatic atrial tachycardias. Other common supraventricular arrhythmias that usually do not require drug therapy are not discussed in this chapter (e.g., premature atrial complexes, wandering atrial pacemaker, sinus arrhythmia, sinus tachycardia). [Pg.73]

AF, atrial fibrillation HF, heart failure 10, intraosseous PSVT, paroxysmal supraventricular tachycardia VF, ventricular fibrillation VT, ventricular tachycardia. [Pg.79]

FIGURE 6-2. Algorithm for the treatment of acute (top portion) paroxysmal supraventricular tachycardia and chronic prevention of recurrences (bottom portion). Note For empiric bridge therapy prior to radiofrequency ablation procedures, calcium channel blockers (or other atrioventricular [AV] nodal blockers) should not be used if the patient has AV reentry with an accessory pathway. (AAD, antiarrhythmic drugs AF, atrial fibrillation AP, accessory pathway AVN, atrioventricular nodal AVNRT, atrioventricular nodal reentrant tachycardia AVRT, atrioventricular reentrant tachycardia DCC, direct-current cardioversion ECG, electrocardiographic monitoring EPS, electrophysiologic studies PRN, as needed VT, ventricular tachycardia.)... [Pg.83]

Cardiovascular manifestations include hypertension and cardiac arrhythmias (e.g., heart block, atrial flutter, paroxysmal atrial tachycardia, ventricular fibrillation, and digitalis-induced arrhythmias). In severe hypokalemia (serum concentration <2.5 mEq/L), ECG effects include ST-segment depression or flattening, T-wave inversion, and U-wave elevation. [Pg.905]

Flecainide is a drug used for arrhythmias and is of particular use in ventricular arrhythmias and paroxysmal atrial fibrillation. Flecainide has a membrane-stabilising activity. Use of flecainide may precipitate serious arrhythmias, even in patients with no history of cardiovascular disease and with otherwise normal hearts. [Pg.169]

Qninidine exhibits all of the pharmacological properties of qninine, including antimalar-ial, fever-redncing, and other properties. Quinidine is used in varions forms of arrhythmia for preventing tachycardia and atrial fibrillation, and particularly for preventing ciliary fibrillation, paroxysmal snpraventricnlar tachycardia, extrasystole, and ventricular tachycardia. However, it is a toxic drug and is nsed relatively rarely. [Pg.247]

Procainamide is intended for treating paroxysmal atrial tachycardia, atrial fibrillation, prematnre ventricular contraction, and ventricnlar tachycardia. For qnickly reaching therapeutic concentrations, parentemal introdnction of procainamide is preferred over cynidine. Synonyms of this drng are amidoprocaine, cardiorythmine, novocainamide, pronestyl, and others. [Pg.247]

Verapamil is used for preventing angina pectoris attacks, arterial hypertension, and treating and preventing supraventricular arrhythmia (paroxysmal supraventricular tachycardia, atrial fibrillation, atrial flutter, extrasystole). Synonyms of this drug are isoptin, calan, fmoptin, falicard, manidone, and many others. [Pg.264]

Oral Premature atrial, AV junctional and ventricular contractions paroxysmal atrial (supraventricular) tachycardia paroxysmal AV junctional rhythm atrial flutter paroxysmal and chronic atrial fibrillation established atrial fibrillation when therapy is appropriate paroxysmal ventricular tachycardia not associated with complete heart block maintenance therapy after electrical conversion of atrial fibrillation or flutter. Parenteral When oral therapy is not feasible or when rapid therapeutic effect is required. [Pg.422]

Immediate-release (IR)-To prolong the time to recurrence of paroxysmal atrial fibrillation/flutter associated with disabling symptoms in patients without structural heart disease. [Pg.447]

Ventricular proarrhythmic effects in patients with atrial fibrillation/flutter A review of the world literature revealed reports of 568 patients treated with oral flecainide for paroxysmal atrial fibrillation/flutter (PAF). Ventricular tachycardia was experienced in 0.4% of these patients. Of 19 patients in the literature with chronic atrial fibrillation (CAF), 10.5% experienced ventricular tachycardia (VT) or ventricular fibrillation (VF). Flecainide is not recommended for use in patients with CAF. Case reports of ventricular proarrhythmic effects in patients treated with flecainide for atrial... [Pg.456]

Atrial fibrillation For the prevention of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms and paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms in patients without structural heart disease. [Pg.457]

Procainamide is an effective antiarrhythmic agent when given in sufficient doses at relatively short (3-4 hours) dosage intervals. Procainamide is useful in the treatment of premature atrial contractions, paroxysmal atrial tachycardia, and atrial fibrillation of recent onset. Procainamide is only moderately effective in converting atrial flutter or chronic atrial fibrillation to sinus rhythm, although it has... [Pg.173]

Diltiazem Paroxysmal supraventricular tachycardia Atrial fibrillation... [Pg.183]

Propranolol alone or in conjunction with digitalis can help control the ventricular rate in patients with atrial flutter or atrial fibrillation. Patients with supraventricular extrasystoles and intermittent paroxysms of atrial fibrillation may benefit from (3-receptor blockade with propranolol. [Pg.183]

CS407 Kosior, D. A., K. J. Filipiak, P. Stolarz, and G. Opolski. Paroxysmal atrial fibrillation in a young female patient CS417 following marijuana intoxication—a case report of possible association. Med Sci Monit 2000 6(2) 386-389. [Pg.113]

Unlabeled Uses Control of hemodynamicallystableventriculartachycardia, control of rapid ventricular rate due to accessory pathway conduction in preexcited atrial arrhythmias, conversion of atrial fibrillation to normal sinus rhythm, in cardiac arrest with persistent ventricular tachycardia or ventricular fibrillation, paroxysmal supraventricular tachycardia, polymorphic ventricular tachycardia or wide complex tachycardia of uncertain origin, prevention of postoperative atrial fibrillation... [Pg.57]

Rapid loading dose for the management and treatment of CHF control ofventricular rate In patients with atrial fibrillation-, treatment and prevention of recurrent paroxysmal atrial tachycardia PO Initially, 0.5-0.75 mg, additional doses of 0.125-0.375 mg at 6-to8-hr intervals. Range 0.75-1.25 mg. IV 0.6-1 mg. [Pg.368]

Maintenance dosage for CHF control of ventricular rate in patients with atrial fibrillation treatment and prevention of recurrent paroxysmal atrial tachycardia PO, IV... [Pg.368]

Contraindications Concurrent use of drugs that prolong the QT interval concurrent use of amiodarone, megestrol, prochlorperazine, or verapamil congenital or acquired prolonged QT syndrome paroxysmal atrial fibrillation severe renal impairment... [Pg.389]

Paroxysmal supraventricular tacfiycardias (PSVT), paroxysmal atrial fibrillation (PAF) ... [Pg.502]

Maintenance of normal sinus rhythm after conversion of atrial fibrillation or flutter, prevention of premature atrial, AV, and ventricular contractions paroxysmal atrial tachycardia paroxysmal AV functional rhythm atrial fibrillation atrial flatter paroxysmal ventricular tachycardia not associated with complete heart block PO 100-600 mg q4-6h. (Long-acting) 324-972 mg q8-12h. IV 200-400 mg. [Pg.1068]

Arrhythmias, including prevention of recurrent paroxysmal supraventricular tachycardia and control of ventricular resting rate in chronic atrial fibrillation or flutter (with di-goxin) PO 240-480 mg/day in 3-4 divided doses. [Pg.1304]

Digitalis (DIGOXIN) 0.25-0.5 mg IV for paroxysmal supraventricular tachycardia (PSVT), atrial flutter and atrial fibrillation... [Pg.190]

It is indicated in prevention of atrial arrhythmia, atrial fibrillation or flutter, paroxysmal supraventricular tachycardia, ventricular premature beats and ventricular tachycardia. [Pg.191]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...